Double carbapenem therapy (DCT) for bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP): from test tube to clinical practice.

Venugopalan, Veena; Nogid, Boris; Le, Thy N; Rahman, Shafiqur M; Bias, Tiffany E

Venugopalan, Veena; Nogid, Boris; Le, Thy N; Rahman, Shafiqur M; Bias, Tiffany E.

Afiliação

Venugopalan V; a Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmac , Gainesville , FL , USA.
Nogid B; b Department of Medical Affairs , Medical Science Liason, Theravance Biopharma, Inc. , South San Francisco , CA , USA.
Le TN; c Department of Clinical Pharmacotherapy , Infectious Diseases, The Brooklyn Hospital Center , Brooklyn , NY , USA.
Rahman SM; d Division of Infectious Diseases , The Brooklyn Hospital Center , Brooklyn , NY , USA.
Bias TE; e Department of Pharmacy , Hahnemann University Hospital , Philadelphia , PA , USA.

Infect Dis (Lond) ; 49(11-12): 867-870, 2017.

Article em En | MEDLINE | ID: mdl-28695756

Assuntos

Carbapenêmicos; Klebsiella pneumoniae; Antibacterianos; Bacteriemia; Humanos; Infecções por Klebsiella

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Carbapenêmicos / Klebsiella pneumoniae Limite: Humans Idioma: En Revista: Infect Dis (Lond) Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google